If you are one of the 5 million people worldwide affected by Lupus, good news may be on the horizon.
Aker BioMarine, a leader in the omega-3 industry, and the Lupus Research Alliance, the leading lupus research organization, will investigate how krill oil can benefit people with lupus, aiming to lessen the severity of symptoms associated with the disease. These two major players in the health field have announced a new partnership, and a clinical trial that may potentially bring new hope to those living with lupus. For the first time, a clinical study that investigates how phospholipid-rich krill oil can benefit people with this chronic autoimmune disease is underway.
What is Lupus?
Systemic lupus erythematosus is a complex chronic autoimmune disease. Over time, the condition can affect the heart, brain, kidneys, liver and more. Lupus also causes inflammation similar to arthritis, but affects the whole body rather than just the joints. It also causes a red rash across the face. Another common problem is extreme fatigue.
What causes lupus in the first place remains largely unknown and there is currently no cure. Anyone can get lupus, but it is most common in females, often striking between the ages of 15- 45-years old.
What is Krill?
Krill are tiny shrimp-like crustaceans found in every ocean around the globe. The specific type found in abundance in the Southern Ocean, called Antarctic Krill, is disputably the Earth’s largest single species marine biomass. While they are small to the human eye, the huge swarms consisting of billions of individual krill can actually be seen from outer space. Krill oil is a pure, natural source of health-promoting EPA and DHA
omega-3 fatty acids that helps support the heart, joint, brain and more.
It is an interesting omega-3 option ecause its fatty acids are largely
bound to phospholipids, which are integral to the body’s cells and cell
membranes. Due to its inherent advantages, krill oil has potential in
serving the world’s omega-3 health needs and is a great nutrient for
clinical studies across the board, such as lupus.
Battling Lupus with Krill, The Study
Our planet is made up of 70% ocean, but only half of 1% of our therapeutic agents are related to the untapped wonders of the sea. Can krill be part of the answer?
The collaboration between Aker BioMarine and the Lupus Research Alliance demonstrates the commitment and dedication needed to find a potential first-of-its-kind natural product for people with lupus. Little headway has been made in the search for new drugs or biological products that can help people with lupus. In fact, there has been only one new drug developed to treat lupus in 60 years, which is why Aker BioMarine is excited about this study and its potential. In fact, Aker BioMarine is well known in the health and wellness industry for taking on challenging initiatives and pushing the boundaries with science and innovation.
This new clinical study will look at how phospholipid-rich krill oil can benefit people with lupus. 76 patients who have been diagnosed with lupus, from 20 different research centers, will be tested. For six-months, each patient will be given a phospholipid-rich krill oil in a blinded study. This means ½ of the patients will be given the actual krill product and the other ½ will be given a placebo. During the last six-months all of the patients will be given the actual study drug.
Test results are expected in the year 2020. In addition to being the financial backer of the program, Aker BioMarine has also been heavily involved in developing the study design and protocol from a scientific perspective, as well as providing the clinical materials for the study.
“It is obvious that many solutions to the big medical riddles must come from the oceans,” said Matts Johansen, CEO at Aker BioMarine “We are so excited that molecules from krill can potentially reduce the symptoms associated with lupus. We are immensely proud to be able to work with the Lupus Research Alliance on this ground-breaking trial.”
Kenneth M. Farber, President, and CEO of Lupus Research Alliance welcomes the possibilities with this study. “We are very pleased to work with Aker BioMarine on bringing a potential therapeutic option to people with lupus,” notes Farber. “The company is thoroughly testing the effectiveness of krill for this group of patients through well-designed scientifically rigorous clinical studies.”
You can learn about the complexity of the illness, the study and much more here.